Iffat A Choudhry, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1225 W Lake St, Melrose Park, IL 60160 Phone: 708-681-1300 |
Dr. Areta Kowal-vern, M.D. Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 1700 Riverwoods Dr Apt 312, Melrose Park, IL 60160 Phone: 708-344-7626 |
Mary Therese Uckerman, MD Pathology - Clinical Pathology/Laboratory Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 W North Ave, Melrose Park, IL 60160 Phone: 708-681-3200 |
Vidya Sriram, Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1225 W Lake St, Melrose Park, IL 60160 Phone: 708-938-7607 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that it will receive a $2 million milestone payment from Merck, known as MSD outside the United States and Canada, under the terms of a development and license collaboration for the development of dinaciclib.
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull.
Shawnee County, Kan., District Court Judge Richard Anderson - who permitted Kansas Attorney General Phill Kline (R) to view edited medical records of 90 women and girls who underwent late-term abortions - on Monday filed a response with the state Supreme Court asking that some information about the case be kept confidential, the AP/Kansas City Star reports.
A new technique offers better sensitivity and accuracy in detecting an essential biomarker of cancer and inflammatory diseases.
The GAVI Alliance "is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline," Reuters reports in an article examining the group's efforts to vaccinate young women with Merck's Gardasil and GSK's Cervarix, "the world's only two approved shots designed to protect against the sexually transmitted human papillomavirus (HPV) that causes the vast majority of cervical cancer cases."
› Verified 9 days ago